Liquid Biopsy Based Circulating Biomarkers in Metastatic Prostate ...

Prostate cancer is the most dominant male malignancy worldwide. The clinical presentation of prostate cancer ranges from localized indolent ...

Of these analytes, the prognostic biomarkers that were seen to be most effective in the clinics are the CTCs (specificity 67%, sensitivity 69%), ...

Blood-based liquid biopsies for prostate cancer: clinical ... - Nature

ctDNA analysis of metastatic prostate cancer patients is able to identify prostate cancer genomic features. When the circulating tumour fraction ...

Liquid Biopsy Based Circulating Biomarkers in Metastatic Prostate ...

Related reading · Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer · Blood-based biomarkers in lung cancer: prognosis ...

Liquid biopsy to personalize treatment for metastatic prostate cancer

Liquid biopsy based circulating biomarkers in metastatic prostate cancer. Front Oncol. 2022; 12: 863472. [4] Puche-Sanz I, Rodríguez-Martínez ...

Current advances of liquid biopsies in prostate cancer - Cell Press

Early detection of PCa could improve overall survival (OS) by preventing metastasis. The prostate-specific antigen (PSA) test is a popular ...

Circulating Biomarkers Predictive of Treatment Response in Patients ...

Metastatic prostate cancer (mPCa) harbors genomic alterations that may predict targeted therapy efficacy. These alterations can be identified ...

The role of liquid biopsies in prostate cancer management

The common liquid biopsy biomarkers are circulating tumor cells (CTCs), extracellular vesicles (EVs), and circulating tumor DNA (ctDNA).

The role of liquid biopsies in prostate cancer management

The common liquid biopsy biomarkers are circulating ... Metastatic prostate cancer invariably progresses to ... The clinical studies based on liquid biopsy ...

Liquid Biopsy Based Circulating Biomarkers in Metastatic Prostate ...

We highlight recent studies involving various circulating biomarkers such as circulating tumor cells, genetic markers, circulating nucleic acids ...

Castration-resistant prostate cancer monitoring by cell-free ...

Figure 1. Scheme of liquid biopsy sampling in relation to different treatment schemes in hormone-sensitive prostate cancer (HSPC) and castration-resistant ...

Detection of PSMA expression on circulating tumor cells by blood ...

A blood-based liquid biopsy assay for recognizing PSMA protein expression on circulating tumor cells may be beneficial for better informing ...

A Biomarker Study of the PRESIDE Phase 3b Trial

Liquid biopsy gives an early indication of docetaxel futility, could guide patient selection for continuing enzalutamide, and identifies cell ...

Metastatic prostate cancer: better monitoring with new liquid biopsy ...

US researchers discuss three blood-based liquid biopsies, namely circulating tumor cells, circulating tumor DNA and tumor-derived exosomes ...

Current advances of liquid biopsies in prostate cancer: Molecular ...

LBs can find cellular, molecular, and metabolomic biomarkers that predict the aggressiveness of PCa and metastasis and prognosis during treatment. Further, LB ...

Liquid Biopsy in Prostate Cancer Management—Current ... - MDPI

Liquid biopsy is employed to assess several body fluids biomarkers, including circulating tumor cells (CTCs), extracellular vesicles (EVs), circulating tumor ...

Liquid Biopsy Based Circulating Biomarkers in Metastatic Prostate ...

Dive into the research topics of 'Liquid Biopsy Based Circulating Biomarkers in Metastatic Prostate Cancer'. Together they form a unique fingerprint. Sort by ...

Liquid Biopsy Based Circulating Biomarkers in Metastatic Prostate ...

We highlight recent studies involving various circulating biomarkers such as circulating tumor cells, genetic markers, circulating nucleic acids, extracellular ...

Liquid Biopsy Based Circulating Biomarkers in Metastatic Prostate ...

Liquid biopsy has opened a plethora of opportunities from early diagnosis to (personalized) therapeutic disease interventions. In this review, we first provide ...

Clinical Applications of Liquid Biopsy in Prostate Cancer - MDPI

Liquid biopsy (LB), encompassing the analysis of circulating tumor material in the blood or urine, has emerged as a powerful tool in the management of ...